Literature DB >> 19361850

The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma.

Kecia N Carroll1, Pingsheng Wu, Tebeb Gebretsadik, Marie R Griffin, William D Dupont, Edward F Mitchel, Tina V Hartert.   

Abstract

BACKGROUND: Infants hospitalized for bronchiolitis have a high rate of early childhood asthma. It is not known whether bronchiolitis severity correlates with the risk of early childhood asthma or with asthma-specific morbidity.
OBJECTIVES: We sought to determine whether a dose-response relationship exists between severity of infant bronchiolitis and both the odds of early childhood asthma and asthma-specific morbidity.
METHODS: We conducted a population-based retrospective birth cohort study of term healthy infants born from 1995-2000 and enrolled in a statewide Medicaid program. We defined bronchiolitis severity by categorizing infants into mutually exclusive groups based on the most advanced level of health care for bronchiolitis. Health care visits, asthma-specific medications, and demographics were identified entirely from Medicaid and linked vital records files. Asthma was ascertained at between 4 and 5.5 years of age, and 1-year asthma morbidity (hospitalization, emergency department visit, or oral corticosteroid course) was determined between 4.5 and 5.5 years among children with prevalent asthma.
RESULTS: Among 90,341 children, 18% had an infant bronchiolitis visit, and these infants contributed to 31% of early childhood asthma diagnoses. Relative to children with no infant bronchiolitis visit, the adjusted odds ratios for asthma were 1.86 (95% CI, 1.74-1.99), 2.41 (95% CI, 2.21-2.62), and 2.82 (95% CI, 2.61-3.03) in the outpatient, emergency department, and hospitalization groups, respectively. Children hospitalized with bronchiolitis during infancy had increased early childhood asthma morbidity compared with that seen in children with no bronchiolitis visit.
CONCLUSION: To our knowledge, this is the first study to demonstrate the dose-response relationship between the severity of infant bronchiolitis and the increased odds of both early childhood asthma and asthma-specific morbidity.

Entities:  

Mesh:

Year:  2009        PMID: 19361850      PMCID: PMC2703291          DOI: 10.1016/j.jaci.2009.02.021

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  41 in total

1.  Modifications to HEDIS and CSTE algorithms improve case recognition of pediatric asthma.

Authors:  Dorothy B Wakefield; Michelle M Cloutier
Journal:  Pediatr Pulmonol       Date:  2006-10

Review 2.  Bronchiolitis to asthma: a review and call for studies of gene-virus interactions in asthma causation.

Authors:  Anne Marie Singh; Paul E Moore; James E Gern; Robert F Lemanske; Tina V Hartert
Journal:  Am J Respir Crit Care Med       Date:  2006-10-19       Impact factor: 21.405

3.  Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children.

Authors:  Daniel J Jackson; Ronald E Gangnon; Michael D Evans; Kathy A Roberg; Elizabeth L Anderson; Tressa E Pappas; Magnolia C Printz; Wai-Ming Lee; Peter A Shult; Erik Reisdorf; Kirsten T Carlson-Dakes; Lisa P Salazar; Douglas F DaSilva; Christopher J Tisler; James E Gern; Robert F Lemanske
Journal:  Am J Respir Crit Care Med       Date:  2008-06-19       Impact factor: 21.405

4.  Prematurity as a predictor of childhood asthma among low-income children.

Authors:  Kevin J Dombkowski; Sonia W Leung; James G Gurney
Journal:  Ann Epidemiol       Date:  2008-03-04       Impact factor: 3.797

5.  Increasing burden and risk factors for bronchiolitis-related medical visits in infants enrolled in a state health care insurance plan.

Authors:  Kecia N Carroll; Tebeb Gebretsadik; Marie R Griffin; Pingsheng Wu; William D Dupont; Edward F Mitchel; Rachel Enriquez; Tina V Hartert
Journal:  Pediatrics       Date:  2008-07       Impact factor: 7.124

6.  Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease.

Authors:  Edy Y Kim; John T Battaile; Anand C Patel; Yingjian You; Eugene Agapov; Mitchell H Grayson; Loralyn A Benoit; Derek E Byers; Yael Alevy; Jennifer Tucker; Suzanne Swanson; Rose Tidwell; Jeffrey W Tyner; Jeffrey D Morton; Mario Castro; Deepika Polineni; G Alexander Patterson; Reto A Schwendener; John D Allard; Gary Peltz; Michael J Holtzman
Journal:  Nat Med       Date:  2008-05-18       Impact factor: 53.440

7.  National surveillance for asthma--United States, 1980-2004.

Authors:  Jeanne E Moorman; Rose Anne Rudd; Carol A Johnson; Michael King; Patrick Minor; Cathy Bailey; Marissa R Scalia; Lara J Akinbami
Journal:  MMWR Surveill Summ       Date:  2007-10-19

8.  Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing.

Authors:  Eric A F Simoes; Jessie R Groothuis; Xavier Carbonell-Estrany; Christian H L Rieger; Ian Mitchell; Linda M Fredrick; Jan L L Kimpen
Journal:  J Pediatr       Date:  2007-07       Impact factor: 4.406

9.  Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation.

Authors:  Nathan W Bartlett; Ross P Walton; Michael R Edwards; Juliya Aniscenko; Gaetano Caramori; Jie Zhu; Nicholas Glanville; Katherine J Choy; Patrick Jourdan; Jerome Burnet; Tobias J Tuthill; Michael S Pedrick; Michael J Hurle; Chris Plumpton; Nigel A Sharp; James N Bussell; Dallas M Swallow; Jurgen Schwarze; Bruno Guy; Jeffrey W Almond; Peter K Jeffery; Clare M Lloyd; Alberto Papi; Richard A Killington; David J Rowlands; Edward D Blair; Neil J Clarke; Sebastian L Johnston
Journal:  Nat Med       Date:  2008-02-03       Impact factor: 53.440

10.  Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma.

Authors:  Merci M H Kusel; Nicholas H de Klerk; Tatiana Kebadze; Vaike Vohma; Patrick G Holt; Sebastian L Johnston; Peter D Sly
Journal:  J Allergy Clin Immunol       Date:  2007-03-13       Impact factor: 10.793

View more
  99 in total

Review 1.  Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma.

Authors:  Amy S Feldman; Yuan He; Martin L Moore; Marc B Hershenson; Tina V Hartert
Journal:  Am J Respir Crit Care Med       Date:  2015-01-01       Impact factor: 21.405

Review 2.  Perinatal and early childhood environmental factors influencing allergic asthma immunopathogenesis.

Authors:  Jonathan M Gaffin; Watcharoot Kanchongkittiphon; Wanda Phipatanakul
Journal:  Int Immunopharmacol       Date:  2014-06-19       Impact factor: 4.932

3.  Association between breast-feeding and severity of acute viral respiratory tract infection.

Authors:  Shanda Vereen; Tebeb Gebretsadik; Tina V Hartert; Patricia Minton; Kimberly Woodward; Zhouwen Liu; Kecia N Carroll
Journal:  Pediatr Infect Dis J       Date:  2014-09       Impact factor: 2.129

Review 4.  Early-life viral infections and the development of asthma: a target for asthma prevention?

Authors:  Daniel J Jackson
Journal:  Curr Opin Allergy Clin Immunol       Date:  2014-04

Review 5.  The role of early life viral bronchiolitis in the inception of asthma.

Authors:  Avraham Beigelman; Leonard B Bacharier
Journal:  Curr Opin Allergy Clin Immunol       Date:  2013-04

6.  Factors Associated With Asthma Diagnosis Within Five Years of a Bronchiolitis Hospitalization: A Retrospective Cohort Study in a High Asthma Prevalence Population.

Authors:  Amanda J Clark; Nancy Dong; Talia Roth; Lindsey C Douglas
Journal:  Hosp Pediatr       Date:  2019-10

7.  Rhinovirus-associated wheeze during infancy and asthma development.

Authors:  Tuomas Jartti; James E Gern
Journal:  Curr Respir Med Rev       Date:  2011-06-01

8.  Respiratory Severity Score Separates Upper Versus Lower Respiratory Tract Infections and Predicts Measures of Disease Severity.

Authors:  Amy S Feldman; Tina V Hartert; Tebeb Gebretsadik; Kecia N Carroll; Patricia A Minton; Kimberly B Woodward; Emma K Larkin; Eva Kathryn Miller; Robert S Valet
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2015-06-01       Impact factor: 1.349

Review 9.  Asthma: clinical expression and molecular mechanisms.

Authors:  Robert F Lemanske; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

10.  Respiratory viruses in bronchiolitis and their link to recurrent wheezing and asthma.

Authors:  Jonathan M Mansbach; Carlos A Camargo
Journal:  Clin Lab Med       Date:  2009-12       Impact factor: 1.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.